Your institution may have access to this item. Find your institution then sign in to continue.
Title
Tovalt.
Abstract
The article provides information on the efficacy, safety and dosing of the Tovalt ODT zolpidem tartrate orally disintegrating tablets made by Biovail Corp. The efficacy of the tablets was evaluated in patients experiencing either transient or chronic insomnia. The most common adverse events reported in patients treated with zolpidem include drowsiness, headache and dizziness. The recommended dose for adults is 10 milligrams, taken immediately before bedtime.